Another Biotech Bites the Dust as Cambridge's Raze Shuts Down Post author:Sam Post published:December 13, 2017 Post category:BioPharma Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace You Might Also Like How Bristol-Myers Squibb Went From Potential Mega-Acquirer to Vulnerable Mega-Target January 26, 2017 BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… January 4, 2018 Trump Endorses 'Right to Try' Experimental Drug Bill at State of the Union Address January 30, 2018
How Bristol-Myers Squibb Went From Potential Mega-Acquirer to Vulnerable Mega-Target January 26, 2017
BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… January 4, 2018
